Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
-
Apr 01, 2024 (filed on Apr 03, 2024)Insider Name:Wood Susan AlysonOwnership Type:Direct OwnershipSecurities:Director Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:13,044Price:--
-
Apr 01, 2024 (filed on Apr 03, 2024)Insider Name:Patel RakeshOwnership Type:Direct OwnershipSecurities:Director Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:22,154Price:--
-
Apr 01, 2024 (filed on Apr 03, 2024)Insider Name:Doyle Michael JohnOwnership Type:Direct OwnershipSecurities:Director Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:9,874Price:--
-
Apr 01, 2024 (filed on Apr 03, 2024)Insider Name:Hricak HedvigOwnership Type:Direct OwnershipSecurities:Director Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:5,415Price:--
-
Apr 01, 2024 (filed on Apr 03, 2024)Insider Name:Sassine AndyOwnership Type:Direct OwnershipSecurities:Director Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:25,259Price:--
-
Feb 22, 2024 (filed on Feb 26, 2024)Insider Name:Hricak HedvigOwnership Type:Direct OwnershipSecurities:Director Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:40,000Price:--
-
Jan 25, 2024 (filed on Jan 25, 2024)Insider Name:Doyle Michael JohnOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:Form 3 : Initial Statement of Beneficial Ownership of Securities# or value acquired/disposed of:--Price:--
-
Jan 23, 2024 (filed on Jan 25, 2024)Insider Name:Doyle Michael JohnOwnership Type:Direct OwnershipSecurities:Director Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:40,000Price:--
-
Jan 12, 2024 (filed on Jan 17, 2024)Insider Name:Sassine AndyOwnership Type:Direct OwnershipSecurities:Director Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:30,265Price:--
-
Jan 03, 2024 (filed on Jan 04, 2024)Insider Name:Lonnqvist EricOwnership Type:Direct OwnershipSecurities:Employee Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:25,000Price:--
Filings by filing date
-
Apr 01, 2024 (filed on Apr 03, 2024)Insider Name:Wood Susan AlysonOwnership Type:Direct OwnershipSecurities:Director Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:13,044Price:--
-
Apr 01, 2024 (filed on Apr 03, 2024)Insider Name:Patel RakeshOwnership Type:Direct OwnershipSecurities:Director Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:22,154Price:--
-
Apr 01, 2024 (filed on Apr 03, 2024)Insider Name:Doyle Michael JohnOwnership Type:Direct OwnershipSecurities:Director Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:9,874Price:--
-
Apr 01, 2024 (filed on Apr 03, 2024)Insider Name:Hricak HedvigOwnership Type:Direct OwnershipSecurities:Director Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:5,415Price:--
-
Apr 01, 2024 (filed on Apr 03, 2024)Insider Name:Sassine AndyOwnership Type:Direct OwnershipSecurities:Director Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:25,259Price:--
-
Feb 22, 2024 (filed on Feb 26, 2024)Insider Name:Hricak HedvigOwnership Type:Direct OwnershipSecurities:Director Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:40,000Price:--
-
Jan 23, 2024 (filed on Jan 25, 2024)Insider Name:Doyle Michael JohnOwnership Type:Direct OwnershipSecurities:Director Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:40,000Price:--
-
Jan 25, 2024 (filed on Jan 25, 2024)Insider Name:Doyle Michael JohnOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:Form 3 : Initial Statement of Beneficial Ownership of Securities# or value acquired/disposed of:--Price:--
-
Jan 12, 2024 (filed on Jan 17, 2024)Insider Name:Sassine AndyOwnership Type:Direct OwnershipSecurities:Director Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:30,265Price:--
-
Jan 03, 2024 (filed on Jan 04, 2024)Insider Name:Lonnqvist EricOwnership Type:Direct OwnershipSecurities:Employee Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:25,000Price:--
News
Biz Brief
Sector: Healthcare | Industry: Advanced Medical Equipment & Technology |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 98 Spit Brook Rd Ste 100 NASHUA NH 03062-5737 |
Tel: | N/A |
Website: | https://www.icadmed.com |
IR: | See website |
Key People | ||
Dana R. Brown Executive Chairman of the Board, President, Chief Executive Officer | Eric Lonnqvist Chief Financial Officer | Michelle Strong Chief Operating Officer |
Jonathan Go Chief Technology Officer | Vasu Avadhanula Chief Product Officer |
Business Overview |
iCAD, Inc. is a global medical technology company, which provides cancer detection and therapy solutions. The Company is focused on providing breast cancer detection solutions built on artificial intelligence (AI) that empowers radiologists to find cancers. Its solutions include advanced image analysis and workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing the most prevalent cancers earlier, and a range of high-performance, AI and computer-aided detection (CAD) systems and workflow solutions for 2D and 3D mammography, magnetic resonance imaging and computed tomography (CT). The Company's Breast AI Suite offers a triple threat of clinically proven cancer detection, density assessment, and risk evaluation solutions, designed to accelerate discovery and improve outcomes. It also offers ProFound AI, a digital breast tomosynthesis (DBT) cancer detection and workflow solution. |
Financial Overview |
For the fiscal year ended 31 December 2023, iCAD Inc revenues decreased 13% to $17.3M. Net loss before extraordinary items decreased 29% to $7M. Revenues reflect Products decrease of 21% to $9.9M. Lower net loss reflects Marketing and sales - Balancing value decrease of 28% to $7.4M (expense), General and administrative - Balancing v decrease of 11% to $8.5M (expense), Interest income increase from $213K to $729K (income). |
Employees: | 67 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $19.73M as of Dec 31, 2023 |
Annual revenue (TTM): | $17.32M as of Dec 31, 2023 |
EBITDA (TTM): | -$7.28M as of Dec 31, 2023 |
Net annual income (TTM): | -$7.01M as of Dec 31, 2023 |
Free cash flow (TTM): | -$5.89M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 26,540,030 as of Mar 22, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |